Clinical Trial Update: A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the amount of evacetrapib that enters the bloodstream in healthy volunteers; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• Evacetrapib

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2019-03-01